# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 14, "Eye ( Lond ) .", "", "<http://ctro/data#Publication_71011> <http://ctro/data#hasJournal> \"Eye ( Lond ) .\"."
1, PublicationYear, 15, 19, "2009", "", "<http://ctro/data#Publication_71011> <http://ctro/data#hasPublicationYear> \"2009\"."
2, Bimatoprost, 102, 113, "Bimatoprost", "", 
6, Title, 102, 220, "Bimatoprost / timolol fixed combination vs latanoprost / timolol fixed combination in open - angle glaucoma patients .", "", "<http://ctro/data#Publication_71011> <http://ctro/data#hasTitle> \"Bimatoprost / timolol fixed combination vs latanoprost / timolol fixed combination in open - angle glaucoma patients .\"."
7, Bima/TimFC, 102, 141, "Bimatoprost / timolol fixed combination", "", 
3, Timolol, 116, 123, "timolol", "", 
4, Latanoprost, 145, 156, "latanoprost", "", 
8, Lat/TimFC, 145, 184, "latanoprost / timolol fixed combination", "", 
5, Timolol, 159, 166, "timolol", "", 
9, OpenAngleGlaucoma, 188, 209, "open - angle glaucoma", "", "<http://ctro/data#ClinicalTrial_71019> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OpenAngleGlaucoma>."
10, Author, 221, 231, "Martinez A", "", "<http://ctro/data#Publication_71011> <http://ctro/data#hasAuthor> \"Martinez A\"."
11, Author, 240, 249, "Sanchez M", "", "<http://ctro/data#Publication_71011> <http://ctro/data#hasAuthor> \"Sanchez M\"."
12, Spain, 380, 385, "Spain", "", "<http://ctro/data#Population_71041> <http://ctro/data#hasCountry> <http://ctro/data#Spain>."
13, ObjectiveDescription, 426, 618, "To evaluate bimatoprost / timolol fixed combination ( BTFC ) vs latanoprost / timolol fixed combination ( LTFC ) given each evening over the 12 - h intraocular pressure ( IOP ) diurnal curve .", "", "<http://ctro/data#ClinicalTrial_71019> <http://ctro/data#hasObjectiveDescription> \"To evaluate bimatoprost / timolol fixed combination ( BTFC ) vs latanoprost / timolol fixed combination ( LTFC ) given each evening over the 12 - h intraocular pressure ( IOP ) diurnal curve .\"."
14, Bimatoprost, 438, 449, "bimatoprost", "", 
17, Bima/TimFC, 438, 477, "bimatoprost / timolol fixed combination", "", "<http://ctro/data#Medication_71089> <http://ctro/data#hasDrug> <http://ctro/data#Bima/TimFC>."
15, Timolol, 452, 459, "timolol", "", 
18, Bima/TimFC, 480, 484, "BTFC", "", 
19, Latanoprost, 490, 501, "latanoprost", "", 
97, Lat/TimFC, 490, 529, "latanoprost / timolol fixed combination", "", "<http://ctro/data#Medication_71096> <http://ctro/data#hasDrug> <http://ctro/data#Lat/TimFC>."
16, Timolol, 504, 511, "timolol", "", 
98, Lat/TimFC, 532, 536, "LTFC", "", 
100, Diurnal_IOP, 574, 610, "intraocular pressure ( IOP ) diurnal", "", "<http://ctro/data#Endpoint_71049> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Diurnal_IOP>."
23, IOP, 597, 600, "IOP", "", 
24, NumberPatientsCT, 651, 653, "54", "", "<http://ctro/data#ClinicalTrial_71019> <http://ctro/data#hasNumberPatientsCT> \"54\"."
87724, Precondition, 654, 662, "patients", "", 
106, NumberAffected, 665, 667, "24", "", 
87724, Precondition, 668, 702, "with primary open - angle glaucoma", "", 
25, Primary_OpenAngleGlaucoma, 673, 702, "primary open - angle glaucoma", "", "<http://ctro/data#ClinicalTrial_71019> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Primary_OpenAngleGlaucoma>."
26, Primary_OpenAngleGlaucoma, 705, 709, "POAG", "", 
107, NumberAffected, 716, 718, "30", "", 
87724, Precondition, 719, 750, "with pseudoexfoliative glaucoma", "", 
27, Glaucoma, 724, 750, "pseudoexfoliative glaucoma", "", "<http://ctro/data#Glaucoma_71040> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Glaucoma>. <http://ctro/data#ClinicalTrial_71019> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Glaucoma_71040>."
28, Glaucoma, 753, 756, "PXG", "", 
29, Prospective, 783, 794, "prospective", "", "<http://ctro/data#ClinicalTrial_71019> <http://ctro/data#hasCTDesign> <http://ctro/data#Prospective>."
30, Randomized, 797, 807, "randomized", "", "<http://ctro/data#ClinicalTrial_71019> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
31, Blind, 810, 828, "evaluator - masked", "", "<http://ctro/data#ClinicalTrial_71019> <http://ctro/data#hasCTDesign> <http://ctro/data#Blind>."
32, SingleCenter, 829, 842, "single centre", "", "<http://ctro/data#ClinicalTrial_71019> <http://ctro/data#hasCTDesign> <http://ctro/data#SingleCenter>."
33, Crossover, 843, 852, "crossover", "", "<http://ctro/data#ClinicalTrial_71019> <http://ctro/data#hasCTDesign> <http://ctro/data#Crossover>."
87723, Precondition, 861, 946, "Patients with an IOP of > or = 19 mmHg , under treatment with prostaglandin analogues", "", "<http://ctro/data#Population_71041> <http://ctro/data#hasPrecondition> \"Patients with an IOP of > or = 19 mmHg , under treatment with prostaglandin analogues\"."
34, IOP, 878, 881, "IOP", "", 
35, mmHg, 895, 899, "mmHg", "", 
87714, Drug, 923, 946, "prostaglandin analogues", "", 
38, Randomized, 954, 964, "randomized", "", 
39, Bima/TimFC, 968, 972, "BTFC", "", 
40, Lat/TimFC, 976, 980, "LTFC", "", 
41, Duration, 987, 996, "12 - week", "", "<http://ctro/data#ClinicalTrial_71019> <http://ctro/data#hasCTduration> \"12 - week\"."
42, Duration, 1022, 1030, "6 - week", "", 
43, Timolol, 1050, 1065, "timolol maleate", "", 
44, DoseValue, 1066, 1071, "0 . 5", "", 
121, Percentage, 1072, 1073, "%", "", 
87728, DoseDescription, 1076, 1096, "one drop in each eye", "", 
45, Frequency, 1097, 1111, "twice each day", "", 
46, IOP, 1205, 1208, "IOP", "", 
87730, TimePoint, 1250, 1258, "baseline", "", 
47, Timolol, 1282, 1297, "timolol maleate", "", 
48, DoseValue, 1298, 1303, "0 . 5", "", 
129, Percentage, 1304, 1305, "%", "", 
49, Frequency, 1306, 1309, "BID", "", 
50, TimePoint, 1314, 1327, "week 6 and 12", "", 
51, TimePoint, 1314, 1320, "week 6", "", 
52, IOP, 1377, 1380, "IOP", "", 
53, Mean, 1383, 1387, "mean", "", "<http://ctro/data#Mean_71051> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_71049> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_71051>."
54, BaseLineValue, 1409, 1415, "22 . 0", "", "<http://ctro/data#Outcome_71103> <http://ctro/data#hasBaselineValue> \"22 . 0\". <http://ctro/data#Outcome_71130> <http://ctro/data#hasBaselineValue> \"22 . 0\"."
55, SdDevBL, 1418, 1423, "1 . 0", "", "<http://ctro/data#Outcome_71103> <http://ctro/data#hasSdDevBL> \"1 . 0\". <http://ctro/data#Outcome_71130> <http://ctro/data#hasSdDevBL> \"1 . 0\"."
56, mmHg, 1426, 1430, "mmHg", "", "<http://ctro/data#Endpoint_71049> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
87731, TimePoint, 1434, 1442, "baseline", "", 
57, ResultMeasuredValue, 1445, 1451, "17 . 7", "", "<http://ctro/data#Outcome_71103> <http://ctro/data#hasResultMeasuredValue> \"17 . 7\"."
59, SdDevResValue, 1454, 1459, "0 . 8", "", "<http://ctro/data#Outcome_71103> <http://ctro/data#hasSdDevResValue> \"0 . 8\"."
62, mmHg, 1462, 1466, "mmHg", "", 
63, Bima/TimFC, 1470, 1474, "BTFC", "", 
58, ResultMeasuredValue, 1481, 1487, "18 . 5", "", "<http://ctro/data#Outcome_71130> <http://ctro/data#hasResultMeasuredValue> \"18 . 5\"."
60, SdDevResValue, 1490, 1495, "0 . 8", "", "<http://ctro/data#Outcome_71130> <http://ctro/data#hasSdDevResValue> \"0 . 8\"."
61, mmHg, 1498, 1502, "mmHg", "", 
64, Lat/TimFC, 1506, 1510, "LTFC", "", 
146, PvalueDiff, 1513, 1524, "P < 0 . 001", "", "<http://ctro/data#DiffBetweenGroups_71157> <http://ctro/data#hasPvalueDiff> \"P < 0 . 001\"."
147, TimePoint, 1610, 1614, "0800", "", 
148, TimePoint, 1617, 1621, "0100", "", 
149, TimePoint, 1624, 1628, "1200", "", 
150, TimePoint, 1631, 1635, "1800", "", 
151, TimePoint, 1642, 1646, "2000", "", 
66, Bima/TimFC, 1658, 1662, "BTFC", "", 
153, PvalueDiff, 1706, 1717, "P < 0 . 001", "", 
159, ObservedResult, 1720, 1779, "The most frequently reported adverse event in the study was", "", 
68, ConjunctivalHyperemia, 1780, 1803, "conjunctival hyperaemia", "", "<http://ctro/data#Endpoint_71054> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#ConjunctivalHyperemia>."
158, ObservedResult, 1806, 1898, "Average hyperaemia scores were slightly but significantly lower in the LTFC treatment period", "", "<http://ctro/data#Outcome_71166> <http://ctro/data#hasObservedResult> \"Average hyperaemia scores were slightly but significantly lower in the LTFC treatment period\"."
69, ConjunctivalHyperemia, 1814, 1824, "hyperaemia", "", 
70, Lat/TimFC, 1877, 1881, "LTFC", "", 
157, PvalueDiff, 1901, 1911, "P = 0 . 04", "", 
72, ConclusionComment, 1929, 2114, "This study suggests that the evening - dosed BTFC provides better IOP control than that of LTFC over 12 h . However , the IOP difference was small and may not be clinically meaningful .", "", "<http://ctro/data#ClinicalTrial_71019> <http://ctro/data#hasConclusionComment> \"This study suggests that the evening - dosed BTFC provides better IOP control than that of LTFC over 12 h . However , the IOP difference was small and may not be clinically meaningful .\"."
73, Bima/TimFC, 1974, 1978, "BTFC", "", 
74, IOP, 1995, 1998, "IOP", "", 
75, Lat/TimFC, 2020, 2024, "LTFC", "", 
76, IOP, 2051, 2054, "IOP", "", 
77, PMID, 2157, 2165, "18535605", "", "<http://ctro/data#Publication_71011> <http://ctro/data#hasPMID> \"18535605\"."
